$ABX

McNealy Sean sold $176K of ABX

McNealy Sean sold 22,700 shares of Abacus Global Management, Inc. (ABX) at $7.74 ($0.18M total) on 2026-09-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · McNealy Sean
Published Sep 23, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ABX
Neutral
high confidence
Mentioned
$ABX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ABXNeutralLow
01

Why it matters

The disclosed sale is modest and does not materially affect valuation, but it adds to the flow of insider activity data.

02

Market read

Routine insider sale with limited market impact; primarily of interest to compliance and monitoring teams.

03

What to watch

Potential upcoming corporate actions or earnings that may change the relevance of this sale.

Relevance 3/10Novelty 3/10Timing: same-day

Background

Form 4 filings provide transparent disclosure of insider transactions, used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$ABXNeutralHigh confidence
Context

SEC Form 4 disclosed insider Sean McNealy sold 22,700 shares of ABX for $175,698 on 2026-09-23.

Expected impact

Minimal short-term impact; price likely unchanged.

Evidence & confidence

The sale size is small relative to total holdings and market cap, unlikely to move the stock.

Counterpoint

If the insider sale signals undisclosed concerns, the stock could face downside pressure.

Key entities

  • Abacus Global Management, Inc.

    Issuer of the stock (ticker ABX) whose insider sold shares.

  • Sean McNealy

    10% owner who executed the sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ABXMed

Analysts’ Opinions Are Mixed on These Financial Stocks: Zurich Insurance Group (OtherZFSVF), Abacus Global Management (ABX) and Blackstone Group (BX)

Analysts updated ratings on three financial stocks: Zurich Insurance Group (ZFSVF) received a Hold rating with a CHF520 price target, Abacus Global Management (ABX) a Buy with a $13.50 target, and Blackstone Group (BX) a Buy with a $140 target. Consensus ratings and targets vary, with ZFSVF at Moderate Buy ($712.30), ABX at Strong Buy ($14.13), and BX at Moderate Buy ($145.50).

$ABXMed

Learn Why The Bull Case For Barrick Mining Stock Could Change Following $3b Buyback

Barrick Mining (TSX:ABX) announced a $3b share buyback, reflecting its cash generation. The company is expanding into copper with projects like Reko Diq and Lumwana. Analysts forecast revenue of $24.9b and earnings of $7.1b by 2029, with a fair value estimate of CA$65.74, a 7% upside from the current share price of CA$61.56. The buyback and copper focus are key factors for investors.

$SSRMMed

TSX Ekes into Green by Noon

The TSX rose 21.03 points to 36,654.15 by noon, with BRP gaining 5.7% after an upgrade. SSR Mining and Barrick Mining declined. The Canadian dollar dipped to 72.25 cents. U.S. jobs data boosted Fed rate hike bets, impacting global markets.

$ABXMed

Abacus Global Management affirms FY26 EPS guidance above estimates

Abacus Global Management (NYSE: ABX) reaffirmed its FY26 adjusted EPS guidance of $1.00 to $1.05, exceeding the analyst estimate of $0.99. The company will report Q2 2026 results on August 6, 2026, with a conference call scheduled for the same day. Abacus specializes in alternative asset management and data-driven financial solutions.

$ABXHigh

Abacus Q2 Revenue Rises 30%, Adjusted Net Income Beats Guidance – Minichart

Abacus Global Management (NYSE: ABX) reported Q2 2026 revenue of $73.0M, up 30% YoY. Adjusted net income exceeded guidance at $27.1M. Adjusted EBITDA rose 27% to $39.9M, maintaining a 55% margin. The company deployed $200M in capital, up 62% YoY, and raised its quarterly target to $150M-$175M. It also changed its valuation methodology to a market-based approach. Asset management raised over $1B in the last year, with annualized distributions reaching 10%.